Avalere Health
An Inovalon Company

Evidence Generation & Value Demonstration

Strengthen Your Value

With today’s focus on the “triple aim”—improving the experience of care, improving the health of populations, and reducing per capita costs of healthcare—demands for high-quality, accurate, and evidence-based information have never been higher. Life science companies are being asked to provide more evidence about product value, including information on effectiveness, costs, and risks of new or existing therapies. With consumers and other industry stakeholders placing an increasing emphasis on data to make their decisions, health plans and providers face a similar challenge to demonstrate value. Avalere develops, implements, and evaluates strategies for improved data collection, integration, and utilization to measure and demonstrate the value of healthcare treatments and services across the patient care continuum.

What's Your Challenge?

  • ​Study Design
  • ​Registry Design, Implementation, and Evaluation
  • Real-World Evidence Generation
  • ​Legislative/Regulatory Tracking

Complementary Products


Meet a few of our experts ready to partner with you.

All Staff

Kristi Mitchell

Senior Vice President


Kristi Mitchell, Senior Vice President, leads client engagements involving the use of clinical data for strategic decision-making across multiple industries, including life sciences, health plans, and professional societies. In this capacity, she provides strategic guidance for innovative collection and utilization of data, as well as, oversees the diffusion of best practice in quality measurement development, implementation, and evaluation across multiples industries.

Prior to joining Avalere, Kristi worked at the American College of Cardiology (ACC), leading the development of the National Cardiovascular Data Registry, most recently as the Chief Science Officer. Prior to the ACC, she assessed the impact of public health policies, programs, and practices on health outcomes at Battelle Centers for Public Health Policy and Evaluation and at the Institute for Health Policy Studies at the University of California, San Francisco.

Kristi has an AB in Human Biology and Public Policy from Brown University and a MPH in Public Health Policy Administration and Epidemiology from University of Michigan. She sits on the FDA MDEpiNet Interim Advisory Committee and the Pew Trust Future of Medical Device Registry Stakeholder Group.

Joseph Lynch



Joseph Lynch, Director, supports clients through the use of clinical data for strategic decision-making. With a background in the use of clinically-enriched administrative data and data derived from clinicians and patients, he assists clients with using clinical data for strategic decision making, implementation of local quality improvement efforts, and development of business strategies to support data collection and integration across health care settings. Joseph has special expertise in designing and implementing patient registries and developing and validating performance measures.

Prior to joining Avalere, Joseph was a Director at Remedy Informatics where he managed the design and implementation of CV clinical registries as well as developed and validated registry-based performance measures for quality reporting and research.  Prior to that, Joseph held Senior Director positions at Inovalon where his contributions ranged from managing strategic application of EHR initiative capabilities to support expansion of ACO and HIE capabilities within the organization to consulting with professional societies in designing, implementing and maintaining clinical registries.  

Joseph has an Associate of Arts, Nursing, from Montgomery College and is a Registered Nurse.

Morenike Ayo-Vaughan

Senior Associate


Morenike Ayo-Vaughan, Senior Associate, provides research support for clients within the field of healthcare quality measurement and improvement.  Morenike has experience in clinical guidelines development, health policy research, and hospital administration.

Prior to joining Avalere, Morenike was a Practice Operations Associate for Privia Health, creating the framework for CMS Meaningful Use program for multispecialty providers and conducting analyses to examine the effectiveness of population health interventions. Prior to that, as a Lean Six Sigma Consultant to the Lombardi Cancer Center, she performed analysis and made recommendations around patient clinical experiences.

Morenike has an MS in Health Systems Administration from Georgetown University and a BS in Public Health from Temple University.

Daniel R. Day

Senior Manager

Daniel R.

Daniel R. Day, Senior Manager, advises Avalere clients on changes to FDA frameworks, scientific due diligence reviews, and regulatory strategy. Daniel also has special expertise in bringing analysis and insight into impending federal health legislation.

Prior to joining Avalere, he served as a member of the Scientific Advisory Board and Program Coordinator with Terosin Group, Inc. and as a Visiting Scientist at the University of California at Santa Barbara.

Daniel has a BS in Biological Sciences, an MA in Molecular Cellular Biology, and a PhD in Pharmacology from the University of California at Santa Barbara. 

« Back to Mobile Site